Breadth of Fc-mediated effector function correlates with clinical immunity following human malaria challengeIMMUNITYIF26.32024-06-013OAAI
Feasibility, safety, and impact of the RTS,S/AS01 E malaria vaccine when implemented through national immunisation programmes: evaluation of cluster-randomised introduction of the vaccine in Ghana, Kenya, and MalawiLANCETIF88.52024-04-015OAAI
Complement-mediated serum bactericidal activity of antibodies elicited by the Shigella sonnei GMMA vaccine in adults from a shigellosis-endemic country: Exploratory analysis of a Phase 2a randomized studyFRONTIERS IN IMMUNOLOGYIF5.92022-09-0917OAAI
Undertaking Community Engagement for a Controlled Human Malaria Infection Study in Kenya: Approaches and Lessons LearntFRONTIERS IN PUBLIC HEALTHIF3.42022-04-294OAAI
Arterolane-piperaquine-mefloquine versus arterolane- piperaquine and artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a single-centre, open-label, randomised, non-inferiority trialLANCET INFECTIOUS DISEASESIF312021-10-0111OAAI
Safety and PCR monitoring in 161 semi-immune Kenyan adults following controlled human malaria infectionJCI INSIGHTIF6.12021-09-0818OA
Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination (vol 5, 32, 2020)NPJ VACCINESIF6.52020-10-060OAAI
Risk of pneumococcal bacteremia in Kenyan children with glucose-6-phosphate dehydrogenase deficiencyBMC MEDICINEIF8.32020-06-157OAAI
Cost-effectiveness and social outcomes of a community-based treatment for podoconiosis lymphoedema in the East Gojjam zone, EthiopiaPLOS NEGLECTED TROPICAL DISEASESIF3.42019-10-2316OAAI
Observational study: 27years of severe malaria surveillance in Kilifi, KenyaBMC MEDICINEIF8.32019-07-0827OAAI
Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan AfricaHUMAN VACCINES & IMMUNOTHERAPEUTICSIF3.52019-04-2343OAAI
Carriage and Acquisition of Extended-spectrum β-Lactamase-producing Enterobacterales Among Neonates Admitted to Hospital in Kilifi, KenyaCLINICAL INFECTIOUS DISEASESIF7.32019-03-0433OAAI
Lymphoedema management to prevent acute dermatolymphangioadenitis in podoconiosis in northern Ethiopia (GoLBeT): a pragmatic randomised controlled trialLANCET GLOBAL HEALTHIF182018-07-0151OAAI
Genetic variation in VAC14 is associated with bacteremia secondary to diverse pathogens in African childrenPROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAIF9.12018-03-2713OAAI
Risk of nontyphoidal Salmonella bacteraemia in African children is modified by STAT4NATURE COMMUNICATIONSIF15.72018-03-0924OAAI
Pragmatism in practice: lessons learned during screening and enrollment for a randomised controlled trial in rural northern EthiopiaBMC MEDICAL RESEARCH METHODOLOGYIF3.42018-03-075OAAI
A Phase 2a Randomized Study to Evaluate the Safety and Immunogenicity of the 1790GAHB Generalized Modules for Membrane Antigen Vaccine against Shigella sonnei Administered Intramuscularly to Adults from a Shigellosis-Endemic CountryFRONTIERS IN IMMUNOLOGYIF5.92017-12-2289OAAI
Human genetic and metabolite variation reveals that methylthioadenosine is a prognostic biomarker and an inflammatory regulator in sepsisSCIENCE ADVANCESIF12.52017-03-0375OAAI
Seven-Year Efficacy of RTS, S/AS01 Malaria Vaccine among Young African ChildrenNEW ENGLAND JOURNAL OF MEDICINEIF78.52016-06-30326OAAI